Denmark· DK-28103057398
Avandia
A rosiglitazone product containing rosiglitazonmaleat, registered in Denmark by SmithKline Beecham plc. The same ATC class is registered in 5 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Rosiglitazone is registered in 5 of 19 countries.
Countries holding a registration under ATC A10BG02 (rosiglitazone), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 2 of them publish a price we can compare per daily dose
Rosiglitazone · ATC A10BG02
5 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ROSIGLITAZONMALEAT
- Manufacturer
- SmithKline Beecham plc
- Country
- Denmark (DK)
- ATC code
- A10BG02
- ATC class
- Rosiglitazone
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 2, 2026
Packs & prices · 1
- dk_varenummer28103057398
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
703 interactions on record for rosiglitazone.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rosiglitazone · interactions on record
703 records
- 8 severe
- 301 moderate
- 42 minor
- 352 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rosiglitazone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b81610a3-c31b-4796-920e-6d835f3fddd5 GET /v1/drugs/b81610a3-c31b-4796-920e-6d835f3fddd5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "2 mg",
"auth_role": "MOD",
"dk_drugid": "28103057398",
"substance": "ROSIGLITAZONMALEAT",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "36718"
}See everything about rosiglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.